Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Buffers and Standards
  4. Chromatography Standards
  5. Drug Standards
  6. 111012362

Nitisinone Pharmaceutical Secondary Standard, Certified Reference Material, MilliporeSigma™ Supelco™

Catalog No. 111012362 Shop All MilliporeSigma Supelco Products
Change view
Click to view available options
Quantity:
1 g
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
11-101-2362 1 g
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 11-101-2362 Supplier MilliporeSigma Supelco Supplier No. PHR17311G
Only null left
Add to Cart
Add to Cart

Description

Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards. Nitisinone is a medication, effectively used for the treatment and maintainence of alkaptonuria, an autosomal recessive disease. Its mode of action involves the inhibition of second enzyme in the tyrosine pathway, 4-hydroxyphenylpyruvate dioxygenase that produces HGA from 4-hydroxyphenylpyruvate.
TRUSTED_SUSTAINABILITY

Specifications

CAS 104206-65-7
Linear Formula C14H10F3NO5
MDL Number MFCD01752192
Synonym Nitisinone; 2-(2-Nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione; 2-[2-Nitro-4-(trifluoromethyl)benzoyl]cyclohexane-1,3-dione; NTBC; Nitisone; SC 0735
Quantity 1 g
Formula Weight 329.23
Grade Certified Reference Material
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.